By Jakob Nielsen, Washington
Novo Nordisk viewed Republican presidential hopeful New Gingrich as a lobbyist in Washington, according to the Danish company’s 2009 annual report in which Novo’s membership of Gingrich’s Center for Health Transformation is listed as “costs for lobbyism”.



























